Zydus Gets Usfda Nod To MarketGeneric Antifungal Medication
Efinaconazole Is An Antifungal Used For The Topical Treatment Of Onychomycosis Of The Toenails Due To Trichophyton Rubrum And Trichophyton Mentagrophytes. Zydus Lifesciences On Monday Said Its Subsidiary Has Received Approval From The Us Health Regulator To Market Antifungal Efinaconazole Topical Solution. Zydus Worldwide Dmcc Has Received Final Approval From The Us Food And Drug Administration (Usfda) To Market The Product, The Drug Firm Said In A Regulatory Filing. Efinaconazole Is An Antifungal Used For The Topical Treatment Of Onychomycosis Of The Toenails Due To Trichophyton Rubrum And Trichophyton Mentagrophytes. The Drug Will Be Manufactured At The Group'S Topical Manufacturing Facility In Ahmedabad
Optimize Your trial insights with Clival Database.
Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.
With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.
To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.
Elevate your trial success rate with the cutting-edge insights from Clival database.
Check it out today and make more informed sourcing decisions! Learn More!
